Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 1008

1.

The Long Journey of TCL1 Transgenic Mice: Lessons Learned in the Last 15 Years.

Pekarsky Y, Drusco A, Kumchala P, Croce CM, Zanesi N.

Gene Expr. 2015;16(3):129-35. doi: 10.3727/105221615X14181438356256.

PMID:
25700368
[PubMed - in process]
2.

Role of MYC-Regulated Long Noncoding RNAs in Cell Cycle Regulation and Tumorigenesis.

Kim T, Jeon YJ, Cui R, Lee JH, Peng Y, Kim SH, Tili E, Alder H, Croce CM.

J Natl Cancer Inst. 2015 Feb 6;107(4). pii: dju505. doi: 10.1093/jnci/dju505. Print 2015 Apr.

PMID:
25663692
[PubMed - in process]
3.

TCL1 targeting miR-3676 is codeleted with tumor protein p53 in chronic lymphocytic leukemia.

Balatti V, Rizzotto L, Miller C, Palamarchuk A, Fadda P, Pandolfo R, Rassenti LZ, Hertlein E, Ruppert AS, Lozanski A, Lozanski G, Kipps TJ, Byrd JC, Croce CM, Pekarsky Y.

Proc Natl Acad Sci U S A. 2015 Feb 17;112(7):2169-74. doi: 10.1073/pnas.1500010112. Epub 2015 Feb 2.

PMID:
25646413
[PubMed - in process]
4.

Mutational landscape of gastric adenocarcinoma in Chinese: Implications for prognosis and therapy.

Chen K, Yang D, Li X, Sun B, Song F, Cao W, Brat DJ, Gao Z, Li H, Liang H, Zhao Y, Zheng H, Li M, Buckner J, Patterson SD, Ye X, Reinhard C, Bhathena A, Joshi D, Mischel PS, Croce CM, Wang YM, Raghavakaimal S, Li H, Lu X, Pan Y, Chang H, Ba S, Luo L, Cavenee WK, Zhang W, Hao X.

Proc Natl Acad Sci U S A. 2015 Jan 27;112(4):1107-12. doi: 10.1073/pnas.1422640112. Epub 2015 Jan 12.

PMID:
25583476
[PubMed - in process]
5.

Computational design of artificial RNA molecules for gene regulation.

Laganà A, Veneziano D, Russo F, Pulvirenti A, Giugno R, Croce CM, Ferro A.

Methods Mol Biol. 2015;1269:393-412. doi: 10.1007/978-1-4939-2291-8_25.

PMID:
25577393
[PubMed - in process]
6.

Synthetic RNAs for Gene Regulation: Design Principles and Computational Tools.

Laganà A, Shasha D, Croce CM.

Front Bioeng Biotechnol. 2014 Dec 11;2:65. doi: 10.3389/fbioe.2014.00065. eCollection 2014. Review.

PMID:
25566532
[PubMed]
Free PMC Article
7.

Two types of BCR interactions are positively selected during leukemia development in the Eμ-TCL1 transgenic mouse model of CLL.

Iacovelli S, Hug E, Bennardo S, Duehren-von Minden M, Gobessi S, Rinaldi A, Suljagic M, Bilbao D, Bolasco G, Eckl-Dorna J, Niederberger V, Autore F, Sica S, Laurenti L, Wang H, Cornall RJ, Clarke SH, Croce CM, Bertoni F, Jumaa H, Efremov DG.

Blood. 2015 Jan 6. pii: blood-2014-07-587790. [Epub ahead of print]

PMID:
25564405
[PubMed - as supplied by publisher]
8.

Expression and prognostic impact of lncRNAs in acute myeloid leukemia.

Garzon R, Volinia S, Papaioannou D, Nicolet D, Kohlschmidt J, Yan PS, Mrózek K, Bucci D, Carroll AJ, Baer MR, Wetzler M, Carter TH, Powell BL, Kolitz JE, Moore JO, Eisfeld AK, Blachly JS, Blum W, Caligiuri MA, Stone RM, Marcucci G, Croce CM, Byrd JC, Bloomfield CD.

Proc Natl Acad Sci U S A. 2014 Dec 30;111(52):18679-84. doi: 10.1073/pnas.1422050112. Epub 2014 Dec 15.

PMID:
25512507
[PubMed - in process]
9.

Role of microRNAs in maintaining cancer stem cells.

Garofalo M, Croce CM.

Adv Drug Deliv Rev. 2015 Jan;81:53-61. doi: 10.1016/j.addr.2014.11.014. Epub 2014 Nov 20.

PMID:
25446141
[PubMed - in process]
10.

The self-assembly of anticancer camptothecin-dipeptide nanotubes: a minimalistic and high drug loading approach to increased efficacy.

Kim SH, Kaplan JA, Sun Y, Shieh A, Sun HL, Croce CM, Grinstaff MW, Parquette JR.

Chemistry. 2015 Jan 2;21(1):101-5. doi: 10.1002/chem.201404520. Epub 2014 Nov 10.

PMID:
25384556
[PubMed - in process]
11.

Pathogenetic and diagnostic significance of microRNA deregulation in peripheral T-cell lymphoma not otherwise specified.

Laginestra MA, Piccaluga PP, Fuligni F, Rossi M, Agostinelli C, Righi S, Sapienza MR, Motta G, Gazzola A, Mannu C, Sabattini E, Bacci F, Tabanelli V, Sacchetti CA, Barrese TZ, Etebari M, Melle F, Clò A, Gibellini D, Tripodo C, Inghirami G, Croce CM, Pileri SA.

Blood Cancer J. 2014 Nov 7;4:259. doi: 10.1038/bcj.2014.78.

PMID:
25382608
[PubMed - in process]
Free PMC Article
12.

A large scale expression study associates uc.283-plus lncRNA with pluripotent stem cells and human glioma.

Galasso M, Dama P, Previati M, Sandhu S, Palatini J, Coppola V, Warner S, Sana ME, Zanella R, Abujarour R, Desponts C, Teitell MA, Garzon R, Calin G, Croce CM, Volinia S.

Genome Med. 2014 Oct 2;6(10):76. doi: 10.1186/s13073-014-0076-4. eCollection 2014.

PMID:
25352916
[PubMed]
Free PMC Article
13.

FHIT suppresses epithelial-mesenchymal transition (EMT) and metastasis in lung cancer through modulation of microRNAs.

Suh SS, Yoo JY, Cui R, Kaur B, Huebner K, Lee TK, Aqeilan RI, Croce CM.

PLoS Genet. 2014 Oct 23;10(10):e1004652. doi: 10.1371/journal.pgen.1004652. eCollection 2014 Oct.

PMID:
25340791
[PubMed - in process]
Free PMC Article
14.

MicroRNA regulation of tumorigenesis, cancer progression and interpatient heterogeneity: towards clinical use.

Nana-Sinkam S, Croce CM.

Genome Biol. 2014 Aug 31;15(9):445. [Epub ahead of print]

PMID:
25315999
[PubMed - as supplied by publisher]
15.

Pluripotent stem cell miRNAs and metastasis in invasive breast cancer.

Volinia S, Nuovo G, Drusco A, Costinean S, Abujarour R, Desponts C, Garofalo M, Baffa R, Aeqilan R, Maharry K, Sana ME, Di Leva G, Gasparini P, Dama P, Marchesini J, Galasso M, Manfrini M, Zerbinati C, Corrà F, Wise T, Wojcik SE, Previati M, Pichiorri F, Zanesi N, Alder H, Palatini J, Huebner KF, Shapiro CL, Negrini M, Vecchione A, Rosenberg AL, Croce CM, Garzon R.

J Natl Cancer Inst. 2014 Oct 11;106(12). pii: dju324. doi: 10.1093/jnci/dju324. Print 2014 Dec. Erratum in: J Natl Cancer Inst. 2014 Nov:106(11):dju373doi:10.1093/jnci/dju373. Garzon, Maria Elena Sana Ramiro [Corrected to Garzon, Ramiro and Sana, Maria Elena].

PMID:
25306216
[PubMed - indexed for MEDLINE]
16.

MicroRNA and cancer--a brief overview.

Acunzo M, Romano G, Wernicke D, Croce CM.

Adv Biol Regul. 2015 Jan;57:1-9. doi: 10.1016/j.jbior.2014.09.013. Epub 2014 Sep 28.

PMID:
25294678
[PubMed - in process]
17.

MicroRNA 29 targets nuclear factor-κB-repressing factor and Claudin 1 to increase intestinal permeability.

Zhou Q, Costinean S, Croce CM, Brasier AR, Merwat S, Larson SA, Basra S, Verne GN.

Gastroenterology. 2015 Jan;148(1):158-169.e8. doi: 10.1053/j.gastro.2014.09.037. Epub 2014 Sep 30.

PMID:
25277410
[PubMed - in process]
18.

Transcribed ultraconserved noncoding RNAs (T-UCR) are involved in Barrett's esophagus carcinogenesis.

Fassan M, Dall'Olmo L, Galasso M, Braconi C, Pizzi M, Realdon S, Volinia S, Valeri N, Gasparini P, Baffa R, Souza RF, Vicentini C, D'Angelo E, Bornschein J, Nuovo GJ, Zaninotto G, Croce CM, Rugge M.

Oncotarget. 2014 Aug 30;5(16):7162-71.

PMID:
25216530
[PubMed - in process]
Free PMC Article
19.

Human HMGA2 protein overexpressed in mice induces precursor T-cell lymphoblastic leukemia.

Efanov A, Zanesi N, Coppola V, Nuovo G, Bolon B, Wernicle-Jameson D, Lagana A, Hansjuerg A, Pichiorri F, Croce CM.

Blood Cancer J. 2014 Jul 11;4:e227. doi: 10.1038/bcj.2014.46.

PMID:
25014774
[PubMed - in process]
Free PMC Article
20.

Role of miR-15/16 in CLL.

Pekarsky Y, Croce CM.

Cell Death Differ. 2015 Jan;22(1):6-11. doi: 10.1038/cdd.2014.87. Epub 2014 Jun 27.

PMID:
24971479
[PubMed - in process]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk